Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Stanley B Cohen

1-50 of 109 results

View this query on the Wikidata Query Service
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

scientific article published in September 2006
The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had

scientific article published on 01 January 2006
Denosumab in postmenopausal women with low bone mineral density

scientific article
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

scientific article published on August 9, 2012
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

article
Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression

scientific article published on 01 July 2004
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study

scientific article
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate

scientific article
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial

scientific article published on 01 March 2002
Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthri

scientific article published on November 2006
Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion

article
A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone

scientific article published on 17 October 2011
Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD

scientific article published on 01 December 2007
Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis

scientific article published in February 2009
Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis

scientific article
A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee

scientific article published on July 29, 2011
Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis

scientific article
Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates

scientific article published on 03 September 2009
A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca

scientific article published in March 2002
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials.

scientific article
Efficacy and Safety of Retreatment in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from the SUNRISE Trial

scientific article published on March 1, 2010
Kinase inhibitors: a new approach to rheumatoid arthritis treatment

scientific article published on May 2010
Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus

scientific article published in September 2004
Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.

scientific article published on February 2006
Immune-mediated inner ear disease: 10-year experience

scientific article
Analysis of Infections and All‐Cause Mortality in Phase II, Phase III, and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis

scientific article published on November 1, 2014
Etanercept treatment for autoimmune inner ear disease: results of a pilot placebo-controlled study

scientific article published on September 2005
Multiple courses of rituximab produce sustained clinical and radiographic efficacy and safety in patients with rheumatoid arthritis and an inadequate response to 1 or more tumor necrosis factor inhibitors: 5-year data from the REFLEX study

scientific article
A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469, a p38 Mitogen-activated Protein Kinase Inhibitor, in Patients with Active Rheumatoid Arthritis

scientific article published on 01 February 2011
Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies

scientific article published on October 2005
Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study

scientific article published on 5 June 2017
Co‐administration of the JAK inhibitor CP‐690,550 and methotrexate is well tolerated in patients with rheumatoid arthritis without need for dose adjustment

scientific article published on February 1, 2010
Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial

scientific article published in June 2009
The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis

scientific article published on June 2004
The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis

scientific article published on May 2004
A phase I pharmacokinetics trial comparing PF‐05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis

scientific article published on 22 February 2016
Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate

scientific article
Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort

scientific article published on June 2008
Brief Report: A Phase IIb Trial of a Novel Extended-Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis

scientific article published on 31 October 2017
Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

scientific article published on 23 May 2019
Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study

scholarly article by Jürgen Wollenhaupt et al published 5 April 2019 in Arthritis Research and Therapy
The evolving use of tumor necrosis factor inhibitors in rheumatoid arthritis

scientific article published on 01 October 2004
Updates from B Cell Trials: Efficacy.

scientific article
Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial

scientific article published on 01 March 2003
Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial

scientific article published in May 2004
Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study

scientific article published in April 2018
A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis

scientific article published on 21 June 2017
American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID-19 Pandemic

scientific article published on 29 April 2020
Interleukin 1 receptor antagonist anakinra improves functional status in patients with rheumatoid arthritis.

scientific article published in February 2003
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept

scientific article

Paulina is supported by:

About Paulina

Help